Robert Wynn
- Genetics top 0.5%
- Virus-based gene therapy research 20
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 49
- Acute Myeloid Leukemia Research 18
- Autoimmune and Inflammatory Disorders Research 17
- Physiology top 0.5%
- Lysosomal Storage Disorders Research 63
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 16
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research 21
-
- Acute Lymphoblastic Leukemia research 23
- Co-authors
- J. E. WraithIlaria BellantuonoLeslie J. FairbairnBrian BiggerSimon JonesJaap Jan BoelensM. BaxterSimon N. Jowitt
- Cited by
- GeneticsHematologyPhysiology
- Journals
- Blood (21 papers)Molecular Genetics and Metabolism (19 papers)British Journal of Haematology (17 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Robert Wynn
287 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Genetics 1.8k
- Hematology 1.5k
- Physiology 2.7k
- Immunology 970
- Epidemiology 1.5k
Countries citing papers authored by Robert Wynn
This map shows the geographic impact of Robert Wynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wynn more than expected).
Fields of papers citing papers by Robert Wynn
This network shows the impact of papers produced by Robert Wynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wynn. The network helps show where Robert Wynn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Wynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 39 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 6 | |
| 15 | 2017 | 21 | |
| 16 | 2013 | 99 | |
| 17 | The top 50 prescription medications dispensed in pharmacies in 2001. | 2003 | 4 |
| 18 | The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). | 2001 | 4 |
| 19 | 2000 | 3 | |
| 20 | 1995 | 12 |
About Robert Wynn
Robert Wynn is a scholar working on Hematology, Physiology, Genetics, Immunology and Oncology, having authored 300 papers that have together received 7.9k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (63 papers), Hematopoietic Stem Cell Transplantation (49 papers), Acute Lymphoblastic Leukemia research (23 papers), Cytomegalovirus and herpesvirus research (21 papers), Virus-based gene therapy research (20 papers), Acute Myeloid Leukemia Research (18 papers), Autoimmune and Inflammatory Disorders Research (17 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). The work is most often cited by research in Genetics (1.8k citations), Hematology (1.5k citations), Physiology (2.7k citations), Immunology (970 citations) and Epidemiology (1.5k citations). Robert Wynn has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include J. E. Wraith, Ilaria Bellantuono, Leslie J. Fairbairn, Brian Bigger, Simon Jones, Jaap Jan Boelens, M. Baxter, Simon N. Jowitt, Paul Veys and Kia Langford‐Smith. Their work appears in journals such as Blood, Molecular Genetics and Metabolism, British Journal of Haematology, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.